Cargando…
Research attitudes in families of individuals with Down syndrome: importance for clinical trials
BACKGROUND: Individuals with Down syndrome (DS) are increasingly eligible for clinical trial intervention, particularly for the treatment or prevention of Alzheimer disease (AD). Yet, little is known about research attitudes that may contribute to decisions regarding clinical trial enrollment for pe...
Autores principales: | Lott, Ira T., Kirby, Katharine A., Doran, Eric, Grill, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686118/ https://www.ncbi.nlm.nih.gov/pubmed/36419175 http://dx.doi.org/10.1186/s13195-022-01120-6 |
Ejemplares similares
-
Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017) -
Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012) -
Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome
por: Harp, Jordan P., et al.
Publicado: (2021) -
Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
por: Martini, Alessandra C., et al.
Publicado: (2020) -
Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)